Delivery Order SPE2DB22D2206-SPE2DB25FJJ76
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $117,115.05 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order, issued under contract number 4569060720, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,862.85 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with a completion date of July 22, 2025. This firm fixed price delivery order was awarded without a set-aside designation through competitive procurement procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,880.46 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract—without set-aside designation—represents a child order under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,585.30 to AmerisourceBergen Drug Corp on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order was placed with AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,385.52 by the Defense Logistics Agency (DLA) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This delivery order represents a child contract under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJJ76Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,911.94 to AmerisourceBergen Drug Corp for 100 tablets of Onfivamide 10 mg, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements across diverse therapeutic domains, ranging from specialty medications to generic drugs, vaccines, and medical supplies. This specific delivery order for Onfivamide tablets reflects the company's ongoing role in supplying pharmaceutical commodities through DLA's medical supply chain infrastructure supporting U.S. military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/13/25 |